Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-07-01FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approves a supplemental application for Bupropion hydrochloride (ANDA 076143) submitted by BluePoint Laboratories.
-
FDA approval · 2009-06-22FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for generic citalopram.
-
FDA approval · 2009-04-23FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth Pharmaceuticals (a Pfizer subsidi…
-
FDA approval · 2009-04-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline hydrochloride from Granules Pharmaceuticals Inc., indicating approval of a modificati…
-
FDA approval · 2009-04-06FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for a generic citalopram product from Hikma Pharmaceuticals USA Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-04-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited, approving changes related to th…
-
FDA approval · 2009-03-24FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Actavis Pharma, Inc.)
FDA approved a generic sustained-release formulation of bupropion hydrochloride for major depressive disorder and seasonal affective disorde…
-
FDA approval · 2009-03-19FDA Approved: FLUOXETINE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original ANDA for fluoxetine from Alembic Pharmaceuticals Limited, enabling a generic version of fluoxetine to be marketed.
-
FDA approval · 2009-03-19FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Fluoxetine by Aurobindo Pharma Limited, enabling a generic Fluoxetine product. The approved indica…
-
FDA approval · 2009-03-11FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved a supplemental application for a generic citalopram product, enabling its market entry. The applicant is Chartwell Governme…
-
FDA approval · 2009-03-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited. This approval authorizes a gene…
-
FDA approval · 2009-03-06FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for citalopram hydrobromide from Aurobindo Pharma Limited, indicating an approved modification to th…
-
FDA approval · 2009-02-27FDA Approved: CITALOPRAM HYDROBROMIDE — Original Application (Glenmark Therapeutics Inc., USA)
FDA approved Glenmark Therapeutics' generic citalopram hydrobromide under Original Application (ANDA 077654). Indication is major depressive…
-
FDA approval · 2009-02-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, a generic version of the antidepressant …
-
FDA approval · 2009-01-30FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by ROERIG.
-
FDA approval · 2009-01-30FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for PAROXETINE HYDROCHLORIDE from Apotex Corp.
-
FDA approval · 2009-01-30FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride), authorizing a generic version under the exist…
-
FDA approval · 2009-01-30FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approves a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2009-01-30FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for an extended-release formulation of Pristiq (desvenlafaxine succinate) by Wyeth Pharmaceutica…
-
FDA approval · 2009-01-30FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
FDA approves a supplemental application for Celexa (citalopram) from Allergan, Inc.
-
FDA approval · 2009-01-27FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for venlafaxine hydrochloride, enabling marketing of a generic venlafaxine hydrochloride produc…
-
FDA approval · 2009-01-23FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Citalopram from Torrent Pharmaceuticals Limited, confirming approval of a supplemental change to…
-
FDA approval · 2009-01-14FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram hydrobromide manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2009-01-13FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Citalopram hydrobromide from Aurobindo Pharma Limited, authorizing its approval as a generic ant…
-
FDA approval · 2009-01-09FDA Approved: VENLAFAXINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a generic venlafaxine product under Heritage Pharmaceuticals’ original ANDA, for the treatment of major depressive disorder and…